A study in 28 patients with metastatic melanoma previously reported that baseline melanoma biopsies from ICI-resistant patients display a higher expression of the MCP-2 coding gene (i.e., CCL8) compared to responding baseline tumours.32 This evidence concerns the gene CCL8 and metastatic melanoma.